Struggling genetic testing 23andMe is looking for a buyer for the virtual care business it acquired in 2021, Business Insider ...

Genetic testing firm 23andMe is reportedly considering the sale of its telehealth division, Lemonaid Health, according to ...

Biotech company 23andMe had a rough 2024, including a $30 million settlement payment after customer data was compromised.

Me (ME) has been quietly exploring a possible sale of its telehealth business, Lemonaid, according to Business Insider.Stay Ahead of the ...

Two of the most popular brands are Ancestry and 23andMe. To learn more, we outlined the pros, cons and factors to consider. However, since this comparison was first published, 23andMe has ...

It remains unknown how many patients are affected by the incident. The Qilin ransomware group claims to have leaked 400 ...

SUNNYVALE, Calif. and LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics company, today announced the launch of Discover23®, a new research offering ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

The 23andMe Health + Ancestry Personal Genetic DNA Test offers just that — an opportunity to kickstart these goals by providing valuable insights into your genetic makeup and ancestral origins.

23andMe, born from the techno-optimism of the Human Genome Project, revolutionized direct-to-consumer genetic testing. But with its valuation now in freefall, mounting layoffs and its board ...

23andMe faced major hurdles in 2024, including a $30 million settlement related to compromised data. 23andMe is now restructuring its business operations to reduce costs and streamline operations.